nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—hypertension—type 2 diabetes mellitus	0.377	1	CtDrD
Clonidine—ADRA2A—type 2 diabetes mellitus	0.0956	0.464	CbGaD
Clonidine—CYP1A2—type 2 diabetes mellitus	0.0664	0.322	CbGaD
Clonidine—CYP3A4—type 2 diabetes mellitus	0.0439	0.213	CbGaD
Clonidine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.022	0.0851	CbGbCtD
Clonidine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.02	0.0773	CbGbCtD
Clonidine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.019	0.0733	CbGbCtD
Clonidine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.016	0.062	CbGbCtD
Clonidine—SLC22A3—Metformin—type 2 diabetes mellitus	0.0134	0.0516	CbGbCtD
Clonidine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0132	0.051	CbGbCtD
Clonidine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0127	0.0489	CbGbCtD
Clonidine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0105	0.0407	CbGbCtD
Clonidine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00938	0.0362	CbGbCtD
Clonidine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0079	0.0305	CbGbCtD
Clonidine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00716	0.0277	CbGbCtD
Clonidine—SLC22A1—Metformin—type 2 diabetes mellitus	0.00687	0.0265	CbGbCtD
Clonidine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00678	0.0262	CbGbCtD
Clonidine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00639	0.0247	CbGbCtD
Clonidine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00631	0.0244	CbGbCtD
Clonidine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0059	0.0228	CbGbCtD
Clonidine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00564	0.0218	CbGbCtD
Clonidine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00562	0.0217	CbGbCtD
Clonidine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00533	0.0206	CbGbCtD
Clonidine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00514	0.0199	CbGbCtD
Clonidine—CYP3A5—Losartan—type 2 diabetes mellitus	0.00488	0.0188	CbGbCtD
Clonidine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00484	0.0187	CbGbCtD
Clonidine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00466	0.018	CbGbCtD
Clonidine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00464	0.0179	CbGbCtD
Clonidine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00449	0.0174	CbGbCtD
Clonidine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00406	0.0157	CbGbCtD
Clonidine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00363	0.014	CbGbCtD
Clonidine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00347	0.0134	CbGbCtD
Clonidine—ABCB1—Losartan—type 2 diabetes mellitus	0.00318	0.0123	CbGbCtD
Clonidine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00308	0.0119	CbGbCtD
Clonidine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00295	0.0114	CbGbCtD
Clonidine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00295	0.0114	CbGbCtD
Clonidine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00279	0.0108	CbGbCtD
Clonidine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00208	0.00804	CbGbCtD
Clonidine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0019	0.00735	CbGbCtD
Clonidine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00152	0.108	CbGeAlD
Clonidine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00102	0.0725	CbGeAlD
Clonidine—Lofexidine—ADRA2A—type 2 diabetes mellitus	0.000624	0.267	CrCbGaD
Clonidine—SLC6A2—nerve—type 2 diabetes mellitus	0.000575	0.0408	CbGeAlD
Clonidine—NISCH—islet of Langerhans—type 2 diabetes mellitus	0.00054	0.0383	CbGeAlD
Clonidine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000522	0.037	CbGeAlD
Clonidine—NISCH—nephron tubule—type 2 diabetes mellitus	0.000435	0.0309	CbGeAlD
Clonidine—Brimonidine—ADRA2A—type 2 diabetes mellitus	0.000402	0.172	CrCbGaD
Clonidine—NISCH—pancreas—type 2 diabetes mellitus	0.00038	0.0269	CbGeAlD
Clonidine—NISCH—cortex of kidney—type 2 diabetes mellitus	0.000372	0.0264	CbGeAlD
Clonidine—Tizanidine—ADRA2A—type 2 diabetes mellitus	0.000368	0.157	CrCbGaD
Clonidine—Apraclonidine—ADRA2A—type 2 diabetes mellitus	0.000359	0.153	CrCbGaD
Clonidine—NISCH—adipose tissue—type 2 diabetes mellitus	0.000345	0.0244	CbGeAlD
Clonidine—ADRA1B—kidney—type 2 diabetes mellitus	0.000326	0.0231	CbGeAlD
Clonidine—SLC22A4—nephron tubule—type 2 diabetes mellitus	0.000288	0.0204	CbGeAlD
Clonidine—Tizanidine—CYP1A2—type 2 diabetes mellitus	0.000256	0.109	CrCbGaD
Clonidine—SLC22A4—kidney—type 2 diabetes mellitus	0.000253	0.0179	CbGeAlD
Clonidine—SLC22A4—cortex of kidney—type 2 diabetes mellitus	0.000246	0.0175	CbGeAlD
Clonidine—NISCH—liver—type 2 diabetes mellitus	0.000242	0.0171	CbGeAlD
Clonidine—SLC22A1—kidney—type 2 diabetes mellitus	0.000241	0.0171	CbGeAlD
Clonidine—SLC22A3—kidney—type 2 diabetes mellitus	0.00023	0.0163	CbGeAlD
Clonidine—SLC22A4—adipose tissue—type 2 diabetes mellitus	0.000228	0.0162	CbGeAlD
Clonidine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000217	0.0154	CbGeAlD
Clonidine—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.000207	0.0147	CbGeAlD
Clonidine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000207	0.0147	CbGeAlD
Clonidine—SLC22A5—retina—type 2 diabetes mellitus	0.000202	0.0143	CbGeAlD
Clonidine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000199	0.0141	CbGeAlD
Clonidine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000197	0.014	CbGeAlD
Clonidine—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.00019	0.0135	CbGeAlD
Clonidine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000187	0.0133	CbGeAlD
Clonidine—ADRA2C—kidney—type 2 diabetes mellitus	0.000175	0.0124	CbGeAlD
Clonidine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000174	0.0123	CbGeAlD
Clonidine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.00017	0.0121	CbGeAlD
Clonidine—SLC22A5—kidney—type 2 diabetes mellitus	0.000167	0.0119	CbGeAlD
Clonidine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000166	0.0118	CbGeAlD
Clonidine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000165	0.0117	CbGeAlD
Clonidine—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000163	0.0116	CbGeAlD
Clonidine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000157	0.0112	CbGeAlD
Clonidine—SLC22A1—liver—type 2 diabetes mellitus	0.000152	0.0108	CbGeAlD
Clonidine—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000151	0.0107	CbGeAlD
Clonidine—CYP1A1—kidney—type 2 diabetes mellitus	0.00015	0.0106	CbGeAlD
Clonidine—CYP3A5—kidney—type 2 diabetes mellitus	0.000146	0.0104	CbGeAlD
Clonidine—SLC22A3—liver—type 2 diabetes mellitus	0.000145	0.0103	CbGeAlD
Clonidine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000145	0.0103	CbGeAlD
Clonidine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000142	0.0101	CbGeAlD
Clonidine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000138	0.00982	CbGeAlD
Clonidine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000136	0.00963	CbGeAlD
Clonidine—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000135	0.00956	CbGeAlD
Clonidine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000132	0.00934	CbGeAlD
Clonidine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000126	0.00891	CbGeAlD
Clonidine—ADRA1A—liver—type 2 diabetes mellitus	0.000116	0.00822	CbGeAlD
Clonidine—ADRA2C—liver—type 2 diabetes mellitus	0.00011	0.00783	CbGeAlD
Clonidine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.00011	0.00778	CbGeAlD
Clonidine—CYP3A4—kidney—type 2 diabetes mellitus	0.00011	0.00778	CbGeAlD
Clonidine—CYP2D6—kidney—type 2 diabetes mellitus	0.000108	0.00766	CbGeAlD
Clonidine—SLC22A5—liver—type 2 diabetes mellitus	0.000106	0.0075	CbGeAlD
Clonidine—CYP1A2—liver—type 2 diabetes mellitus	9.58e-05	0.00679	CbGeAlD
Clonidine—CYP1A1—liver—type 2 diabetes mellitus	9.45e-05	0.0067	CbGeAlD
Clonidine—ABCB1—retina—type 2 diabetes mellitus	9.38e-05	0.00665	CbGeAlD
Clonidine—CYP3A5—liver—type 2 diabetes mellitus	9.24e-05	0.00655	CbGeAlD
Clonidine—Diclofenac—CYP2E1—type 2 diabetes mellitus	8.86e-05	0.0379	CrCbGaD
Clonidine—ABCB1—nephron tubule—type 2 diabetes mellitus	8.84e-05	0.00627	CbGeAlD
Clonidine—Diclofenac—CYP1A2—type 2 diabetes mellitus	8.43e-05	0.036	CrCbGaD
Clonidine—ABCB1—cardiovascular system—type 2 diabetes mellitus	7.94e-05	0.00563	CbGeAlD
Clonidine—ABCB1—kidney—type 2 diabetes mellitus	7.77e-05	0.00551	CbGeAlD
Clonidine—ABCB1—pancreas—type 2 diabetes mellitus	7.72e-05	0.00547	CbGeAlD
Clonidine—ABCB1—cortex of kidney—type 2 diabetes mellitus	7.56e-05	0.00536	CbGeAlD
Clonidine—ABCB1—adipose tissue—type 2 diabetes mellitus	7e-05	0.00496	CbGeAlD
Clonidine—CYP3A4—liver—type 2 diabetes mellitus	6.93e-05	0.00492	CbGeAlD
Clonidine—CYP2D6—liver—type 2 diabetes mellitus	6.82e-05	0.00484	CbGeAlD
Clonidine—Diclofenac—CYP3A4—type 2 diabetes mellitus	5.58e-05	0.0239	CrCbGaD
Clonidine—Agitation—Losartan—type 2 diabetes mellitus	5.47e-05	0.000626	CcSEcCtD
Clonidine—Oedema—Metformin—type 2 diabetes mellitus	5.47e-05	0.000626	CcSEcCtD
Clonidine—Tinnitus—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000626	CcSEcCtD
Clonidine—Diclofenac—PTGS2—type 2 diabetes mellitus	5.46e-05	0.0234	CrCbGaD
Clonidine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.45e-05	0.000624	CcSEcCtD
Clonidine—Angioedema—Losartan—type 2 diabetes mellitus	5.44e-05	0.000623	CcSEcCtD
Clonidine—Infection—Metformin—type 2 diabetes mellitus	5.44e-05	0.000622	CcSEcCtD
Clonidine—Insomnia—Valsartan—type 2 diabetes mellitus	5.43e-05	0.000622	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.41e-05	0.000619	CcSEcCtD
Clonidine—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.4e-05	0.000618	CcSEcCtD
Clonidine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.39e-05	0.000617	CcSEcCtD
Clonidine—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.39e-05	0.000617	CcSEcCtD
Clonidine—Chest pain—Irbesartan—type 2 diabetes mellitus	5.39e-05	0.000617	CcSEcCtD
Clonidine—Shock—Metformin—type 2 diabetes mellitus	5.38e-05	0.000616	CcSEcCtD
Clonidine—Insomnia—Orlistat—type 2 diabetes mellitus	5.37e-05	0.000615	CcSEcCtD
Clonidine—Malaise—Losartan—type 2 diabetes mellitus	5.37e-05	0.000615	CcSEcCtD
Clonidine—Anxiety—Irbesartan—type 2 diabetes mellitus	5.37e-05	0.000614	CcSEcCtD
Clonidine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.37e-05	0.000614	CcSEcCtD
Clonidine—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.37e-05	0.000614	CcSEcCtD
Clonidine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.36e-05	0.000613	CcSEcCtD
Clonidine—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.36e-05	0.000613	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000612	CcSEcCtD
Clonidine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.35e-05	0.000612	CcSEcCtD
Clonidine—Somnolence—Valsartan—type 2 diabetes mellitus	5.34e-05	0.000611	CcSEcCtD
Clonidine—Syncope—Losartan—type 2 diabetes mellitus	5.34e-05	0.000611	CcSEcCtD
Clonidine—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.33e-05	0.00061	CcSEcCtD
Clonidine—Discomfort—Irbesartan—type 2 diabetes mellitus	5.32e-05	0.000609	CcSEcCtD
Clonidine—Skin disorder—Metformin—type 2 diabetes mellitus	5.32e-05	0.000608	CcSEcCtD
Clonidine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.29e-05	0.000605	CcSEcCtD
Clonidine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000605	CcSEcCtD
Clonidine—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.27e-05	0.000603	CcSEcCtD
Clonidine—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000603	CcSEcCtD
Clonidine—Palpitations—Losartan—type 2 diabetes mellitus	5.26e-05	0.000602	CcSEcCtD
Clonidine—Nausea—Glimepiride—type 2 diabetes mellitus	5.25e-05	0.0006	CcSEcCtD
Clonidine—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.24e-05	0.0006	CcSEcCtD
Clonidine—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.23e-05	0.000599	CcSEcCtD
Clonidine—Nausea—Sitagliptin—type 2 diabetes mellitus	5.23e-05	0.000599	CcSEcCtD
Clonidine—Asthenia—Glyburide—type 2 diabetes mellitus	5.23e-05	0.000598	CcSEcCtD
Clonidine—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.22e-05	0.000598	CcSEcCtD
Clonidine—Anorexia—Metformin—type 2 diabetes mellitus	5.22e-05	0.000597	CcSEcCtD
Clonidine—Cough—Losartan—type 2 diabetes mellitus	5.2e-05	0.000595	CcSEcCtD
Clonidine—Urticaria—Gliclazide—type 2 diabetes mellitus	5.2e-05	0.000595	CcSEcCtD
Clonidine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.19e-05	0.000594	CcSEcCtD
Clonidine—Alopecia—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000593	CcSEcCtD
Clonidine—Fatigue—Valsartan—type 2 diabetes mellitus	5.18e-05	0.000593	CcSEcCtD
Clonidine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.17e-05	0.000592	CcSEcCtD
Clonidine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.17e-05	0.000592	CcSEcCtD
Clonidine—Oedema—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000591	CcSEcCtD
Clonidine—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.16e-05	0.000591	CcSEcCtD
Clonidine—Pruritus—Glyburide—type 2 diabetes mellitus	5.15e-05	0.00059	CcSEcCtD
Clonidine—Mental disorder—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000588	CcSEcCtD
Clonidine—Constipation—Valsartan—type 2 diabetes mellitus	5.14e-05	0.000588	CcSEcCtD
Clonidine—Infection—Irbesartan—type 2 diabetes mellitus	5.13e-05	0.000587	CcSEcCtD
Clonidine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.13e-05	0.000587	CcSEcCtD
Clonidine—Fatigue—Orlistat—type 2 diabetes mellitus	5.12e-05	0.000586	CcSEcCtD
Clonidine—Hypotension—Metformin—type 2 diabetes mellitus	5.11e-05	0.000585	CcSEcCtD
Clonidine—Erythema—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000584	CcSEcCtD
Clonidine—Shock—Irbesartan—type 2 diabetes mellitus	5.08e-05	0.000581	CcSEcCtD
Clonidine—Pain—Orlistat—type 2 diabetes mellitus	5.08e-05	0.000581	CcSEcCtD
Clonidine—Arthralgia—Losartan—type 2 diabetes mellitus	5.07e-05	0.00058	CcSEcCtD
Clonidine—Chest pain—Losartan—type 2 diabetes mellitus	5.07e-05	0.00058	CcSEcCtD
Clonidine—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.07e-05	0.00058	CcSEcCtD
Clonidine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.00058	CcSEcCtD
Clonidine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000579	CcSEcCtD
Clonidine—Anxiety—Losartan—type 2 diabetes mellitus	5.05e-05	0.000578	CcSEcCtD
Clonidine—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000577	CcSEcCtD
Clonidine—Rash—Bromocriptine—type 2 diabetes mellitus	5.02e-05	0.000575	CcSEcCtD
Clonidine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.02e-05	0.000574	CcSEcCtD
Clonidine—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000574	CcSEcCtD
Clonidine—Tension—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000573	CcSEcCtD
Clonidine—Discomfort—Losartan—type 2 diabetes mellitus	5.01e-05	0.000573	CcSEcCtD
Clonidine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.000571	CcSEcCtD
Clonidine—Headache—Bromocriptine—type 2 diabetes mellitus	4.99e-05	0.000571	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.99e-05	0.000571	CcSEcCtD
Clonidine—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.98e-05	0.00057	CcSEcCtD
Clonidine—Nervousness—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000568	CcSEcCtD
Clonidine—Dry mouth—Losartan—type 2 diabetes mellitus	4.96e-05	0.000567	CcSEcCtD
Clonidine—Anorexia—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000563	CcSEcCtD
Clonidine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.91e-05	0.000562	CcSEcCtD
Clonidine—Paraesthesia—Metformin—type 2 diabetes mellitus	4.91e-05	0.000562	CcSEcCtD
Clonidine—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.91e-05	0.000562	CcSEcCtD
Clonidine—ABCB1—liver—type 2 diabetes mellitus	4.91e-05	0.00348	CbGeAlD
Clonidine—Confusional state—Losartan—type 2 diabetes mellitus	4.9e-05	0.000561	CcSEcCtD
Clonidine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.89e-05	0.00056	CcSEcCtD
Clonidine—Dyspnoea—Metformin—type 2 diabetes mellitus	4.88e-05	0.000558	CcSEcCtD
Clonidine—Diclofenac—ALB—type 2 diabetes mellitus	4.87e-05	0.0208	CrCbGaD
Clonidine—Somnolence—Metformin—type 2 diabetes mellitus	4.86e-05	0.000557	CcSEcCtD
Clonidine—Oedema—Losartan—type 2 diabetes mellitus	4.86e-05	0.000556	CcSEcCtD
Clonidine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.86e-05	0.000556	CcSEcCtD
Clonidine—Infection—Losartan—type 2 diabetes mellitus	4.83e-05	0.000553	CcSEcCtD
Clonidine—Hypotension—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000552	CcSEcCtD
Clonidine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.82e-05	0.000551	CcSEcCtD
Clonidine—Tremor—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000547	CcSEcCtD
Clonidine—Shock—Losartan—type 2 diabetes mellitus	4.78e-05	0.000547	CcSEcCtD
Clonidine—Urticaria—Valsartan—type 2 diabetes mellitus	4.77e-05	0.000546	CcSEcCtD
Clonidine—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.77e-05	0.000545	CcSEcCtD
Clonidine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.76e-05	0.000545	CcSEcCtD
Clonidine—Decreased appetite—Metformin—type 2 diabetes mellitus	4.76e-05	0.000544	CcSEcCtD
Clonidine—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.75e-05	0.000544	CcSEcCtD
Clonidine—Tachycardia—Losartan—type 2 diabetes mellitus	4.74e-05	0.000543	CcSEcCtD
Clonidine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000542	CcSEcCtD
Clonidine—Nausea—Bromocriptine—type 2 diabetes mellitus	4.73e-05	0.000542	CcSEcCtD
Clonidine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.72e-05	0.000541	CcSEcCtD
Clonidine—Fatigue—Metformin—type 2 diabetes mellitus	4.72e-05	0.00054	CcSEcCtD
Clonidine—Urticaria—Orlistat—type 2 diabetes mellitus	4.72e-05	0.00054	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000538	CcSEcCtD
Clonidine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.7e-05	0.000538	CcSEcCtD
Clonidine—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.69e-05	0.000537	CcSEcCtD
Clonidine—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.69e-05	0.000537	CcSEcCtD
Clonidine—Asthenia—Gliclazide—type 2 diabetes mellitus	4.69e-05	0.000537	CcSEcCtD
Clonidine—Agitation—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000537	CcSEcCtD
Clonidine—Constipation—Metformin—type 2 diabetes mellitus	4.68e-05	0.000536	CcSEcCtD
Clonidine—Angioedema—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000534	CcSEcCtD
Clonidine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000531	CcSEcCtD
Clonidine—Anorexia—Losartan—type 2 diabetes mellitus	4.63e-05	0.00053	CcSEcCtD
Clonidine—Vomiting—Glyburide—type 2 diabetes mellitus	4.63e-05	0.00053	CcSEcCtD
Clonidine—Pruritus—Gliclazide—type 2 diabetes mellitus	4.63e-05	0.00053	CcSEcCtD
Clonidine—Malaise—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000527	CcSEcCtD
Clonidine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000527	CcSEcCtD
Clonidine—Rash—Glyburide—type 2 diabetes mellitus	4.59e-05	0.000526	CcSEcCtD
Clonidine—Somnolence—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000525	CcSEcCtD
Clonidine—Dermatitis—Glyburide—type 2 diabetes mellitus	4.59e-05	0.000525	CcSEcCtD
Clonidine—Syncope—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000524	CcSEcCtD
Clonidine—Headache—Glyburide—type 2 diabetes mellitus	4.56e-05	0.000522	CcSEcCtD
Clonidine—Hypotension—Losartan—type 2 diabetes mellitus	4.54e-05	0.00052	CcSEcCtD
Clonidine—Palpitations—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000516	CcSEcCtD
Clonidine—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.51e-05	0.000516	CcSEcCtD
Clonidine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000514	CcSEcCtD
Clonidine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.49e-05	0.000514	CcSEcCtD
Clonidine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.48e-05	0.000512	CcSEcCtD
Clonidine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.47e-05	0.000512	CcSEcCtD
Clonidine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.46e-05	0.00051	CcSEcCtD
Clonidine—Cough—Ramipril—type 2 diabetes mellitus	4.46e-05	0.00051	CcSEcCtD
Clonidine—Fatigue—Irbesartan—type 2 diabetes mellitus	4.45e-05	0.00051	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.43e-05	0.000507	CcSEcCtD
Clonidine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.43e-05	0.000507	CcSEcCtD
Clonidine—Constipation—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000505	CcSEcCtD
Clonidine—Pain—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000505	CcSEcCtD
Clonidine—Insomnia—Losartan—type 2 diabetes mellitus	4.4e-05	0.000503	CcSEcCtD
Clonidine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.37e-05	0.000501	CcSEcCtD
Clonidine—Paraesthesia—Losartan—type 2 diabetes mellitus	4.36e-05	0.000499	CcSEcCtD
Clonidine—Urticaria—Metformin—type 2 diabetes mellitus	4.35e-05	0.000498	CcSEcCtD
Clonidine—Arthralgia—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000497	CcSEcCtD
Clonidine—Chest pain—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000497	CcSEcCtD
Clonidine—Dyspnoea—Losartan—type 2 diabetes mellitus	4.33e-05	0.000496	CcSEcCtD
Clonidine—Anxiety—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000496	CcSEcCtD
Clonidine—Nausea—Glyburide—type 2 diabetes mellitus	4.33e-05	0.000495	CcSEcCtD
Clonidine—Abdominal pain—Metformin—type 2 diabetes mellitus	4.33e-05	0.000495	CcSEcCtD
Clonidine—Dizziness—Gliclazide—type 2 diabetes mellitus	4.33e-05	0.000495	CcSEcCtD
Clonidine—Somnolence—Losartan—type 2 diabetes mellitus	4.32e-05	0.000494	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000494	CcSEcCtD
Clonidine—Asthenia—Valsartan—type 2 diabetes mellitus	4.31e-05	0.000493	CcSEcCtD
Clonidine—Discomfort—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000492	CcSEcCtD
Clonidine—Asthenia—Orlistat—type 2 diabetes mellitus	4.26e-05	0.000488	CcSEcCtD
Clonidine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.26e-05	0.000487	CcSEcCtD
Clonidine—Pruritus—Valsartan—type 2 diabetes mellitus	4.25e-05	0.000487	CcSEcCtD
Clonidine—Dry mouth—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000487	CcSEcCtD
Clonidine—Decreased appetite—Losartan—type 2 diabetes mellitus	4.22e-05	0.000483	CcSEcCtD
Clonidine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.22e-05	0.000483	CcSEcCtD
Clonidine—Confusional state—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000481	CcSEcCtD
Clonidine—Pruritus—Orlistat—type 2 diabetes mellitus	4.2e-05	0.000481	CcSEcCtD
Clonidine—Fatigue—Losartan—type 2 diabetes mellitus	4.19e-05	0.00048	CcSEcCtD
Clonidine—Oedema—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000477	CcSEcCtD
Clonidine—Vomiting—Gliclazide—type 2 diabetes mellitus	4.16e-05	0.000476	CcSEcCtD
Clonidine—Constipation—Losartan—type 2 diabetes mellitus	4.16e-05	0.000476	CcSEcCtD
Clonidine—Pain—Losartan—type 2 diabetes mellitus	4.16e-05	0.000476	CcSEcCtD
Clonidine—Rash—Gliclazide—type 2 diabetes mellitus	4.12e-05	0.000472	CcSEcCtD
Clonidine—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.12e-05	0.000472	CcSEcCtD
Clonidine—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.11e-05	0.000471	CcSEcCtD
Clonidine—Urticaria—Irbesartan—type 2 diabetes mellitus	4.1e-05	0.00047	CcSEcCtD
Clonidine—Shock—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000469	CcSEcCtD
Clonidine—Headache—Gliclazide—type 2 diabetes mellitus	4.1e-05	0.000469	CcSEcCtD
Clonidine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000468	CcSEcCtD
Clonidine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.08e-05	0.000467	CcSEcCtD
Clonidine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.08e-05	0.000467	CcSEcCtD
Clonidine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000467	CcSEcCtD
Clonidine—Tachycardia—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000465	CcSEcCtD
Clonidine—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.06e-05	0.000465	CcSEcCtD
Clonidine—Skin disorder—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000463	CcSEcCtD
Clonidine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000461	CcSEcCtD
Clonidine—Feeling abnormal—Losartan—type 2 diabetes mellitus	4e-05	0.000458	CcSEcCtD
Clonidine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.97e-05	0.000455	CcSEcCtD
Clonidine—Dizziness—Valsartan—type 2 diabetes mellitus	3.97e-05	0.000455	CcSEcCtD
Clonidine—Anorexia—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000455	CcSEcCtD
Clonidine—Dizziness—Orlistat—type 2 diabetes mellitus	3.93e-05	0.000449	CcSEcCtD
Clonidine—Asthenia—Metformin—type 2 diabetes mellitus	3.93e-05	0.000449	CcSEcCtD
Clonidine—Hypotension—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000446	CcSEcCtD
Clonidine—Nausea—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.000445	CcSEcCtD
Clonidine—Pruritus—Metformin—type 2 diabetes mellitus	3.87e-05	0.000443	CcSEcCtD
Clonidine—Urticaria—Losartan—type 2 diabetes mellitus	3.86e-05	0.000442	CcSEcCtD
Clonidine—Abdominal pain—Losartan—type 2 diabetes mellitus	3.84e-05	0.00044	CcSEcCtD
Clonidine—Body temperature increased—Losartan—type 2 diabetes mellitus	3.84e-05	0.00044	CcSEcCtD
Clonidine—Vomiting—Valsartan—type 2 diabetes mellitus	3.82e-05	0.000437	CcSEcCtD
Clonidine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.8e-05	0.000435	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000435	CcSEcCtD
Clonidine—Rash—Valsartan—type 2 diabetes mellitus	3.79e-05	0.000434	CcSEcCtD
Clonidine—Dermatitis—Valsartan—type 2 diabetes mellitus	3.79e-05	0.000433	CcSEcCtD
Clonidine—Vomiting—Orlistat—type 2 diabetes mellitus	3.78e-05	0.000432	CcSEcCtD
Clonidine—Insomnia—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000431	CcSEcCtD
Clonidine—Headache—Valsartan—type 2 diabetes mellitus	3.76e-05	0.000431	CcSEcCtD
Clonidine—Diarrhoea—Metformin—type 2 diabetes mellitus	3.74e-05	0.000428	CcSEcCtD
Clonidine—Rash—Orlistat—type 2 diabetes mellitus	3.74e-05	0.000428	CcSEcCtD
Clonidine—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000428	CcSEcCtD
Clonidine—Dermatitis—Orlistat—type 2 diabetes mellitus	3.74e-05	0.000428	CcSEcCtD
Clonidine—Headache—Orlistat—type 2 diabetes mellitus	3.72e-05	0.000426	CcSEcCtD
Clonidine—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000425	CcSEcCtD
Clonidine—Asthenia—Irbesartan—type 2 diabetes mellitus	3.71e-05	0.000424	CcSEcCtD
Clonidine—Somnolence—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000424	CcSEcCtD
Clonidine—Pruritus—Irbesartan—type 2 diabetes mellitus	3.65e-05	0.000418	CcSEcCtD
Clonidine—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000415	CcSEcCtD
Clonidine—Dizziness—Metformin—type 2 diabetes mellitus	3.62e-05	0.000414	CcSEcCtD
Clonidine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.6e-05	0.000412	CcSEcCtD
Clonidine—Fatigue—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000411	CcSEcCtD
Clonidine—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.58e-05	0.00041	CcSEcCtD
Clonidine—Nausea—Valsartan—type 2 diabetes mellitus	3.57e-05	0.000408	CcSEcCtD
Clonidine—Constipation—Ramipril—type 2 diabetes mellitus	3.56e-05	0.000408	CcSEcCtD
Clonidine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.000404	CcSEcCtD
Clonidine—Nausea—Orlistat—type 2 diabetes mellitus	3.53e-05	0.000404	CcSEcCtD
Clonidine—Asthenia—Losartan—type 2 diabetes mellitus	3.49e-05	0.000399	CcSEcCtD
Clonidine—Vomiting—Metformin—type 2 diabetes mellitus	3.48e-05	0.000398	CcSEcCtD
Clonidine—Rash—Metformin—type 2 diabetes mellitus	3.45e-05	0.000395	CcSEcCtD
Clonidine—Dermatitis—Metformin—type 2 diabetes mellitus	3.45e-05	0.000395	CcSEcCtD
Clonidine—Pruritus—Losartan—type 2 diabetes mellitus	3.44e-05	0.000394	CcSEcCtD
Clonidine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000393	CcSEcCtD
Clonidine—Headache—Metformin—type 2 diabetes mellitus	3.43e-05	0.000392	CcSEcCtD
Clonidine—Dizziness—Irbesartan—type 2 diabetes mellitus	3.41e-05	0.000391	CcSEcCtD
Clonidine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.41e-05	0.00039	CcSEcCtD
Clonidine—Diarrhoea—Losartan—type 2 diabetes mellitus	3.33e-05	0.000381	CcSEcCtD
Clonidine—Urticaria—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000379	CcSEcCtD
Clonidine—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000377	CcSEcCtD
Clonidine—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000377	CcSEcCtD
Clonidine—Vomiting—Irbesartan—type 2 diabetes mellitus	3.28e-05	0.000376	CcSEcCtD
Clonidine—Rash—Irbesartan—type 2 diabetes mellitus	3.26e-05	0.000373	CcSEcCtD
Clonidine—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000372	CcSEcCtD
Clonidine—Nausea—Metformin—type 2 diabetes mellitus	3.25e-05	0.000372	CcSEcCtD
Clonidine—Headache—Irbesartan—type 2 diabetes mellitus	3.24e-05	0.00037	CcSEcCtD
Clonidine—Dizziness—Losartan—type 2 diabetes mellitus	3.21e-05	0.000368	CcSEcCtD
Clonidine—Vomiting—Losartan—type 2 diabetes mellitus	3.09e-05	0.000354	CcSEcCtD
Clonidine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000351	CcSEcCtD
Clonidine—Nausea—Irbesartan—type 2 diabetes mellitus	3.07e-05	0.000351	CcSEcCtD
Clonidine—Rash—Losartan—type 2 diabetes mellitus	3.06e-05	0.000351	CcSEcCtD
Clonidine—Dermatitis—Losartan—type 2 diabetes mellitus	3.06e-05	0.00035	CcSEcCtD
Clonidine—Headache—Losartan—type 2 diabetes mellitus	3.04e-05	0.000348	CcSEcCtD
Clonidine—Asthenia—Ramipril—type 2 diabetes mellitus	2.99e-05	0.000342	CcSEcCtD
Clonidine—Pruritus—Ramipril—type 2 diabetes mellitus	2.95e-05	0.000337	CcSEcCtD
Clonidine—Nausea—Losartan—type 2 diabetes mellitus	2.89e-05	0.00033	CcSEcCtD
Clonidine—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000326	CcSEcCtD
Clonidine—Dizziness—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000315	CcSEcCtD
Clonidine—Vomiting—Ramipril—type 2 diabetes mellitus	2.65e-05	0.000303	CcSEcCtD
Clonidine—Rash—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000301	CcSEcCtD
Clonidine—Dermatitis—Ramipril—type 2 diabetes mellitus	2.63e-05	0.0003	CcSEcCtD
Clonidine—Headache—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000299	CcSEcCtD
Clonidine—Nausea—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000283	CcSEcCtD
Clonidine—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.5e-06	2.76e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.49e-06	2.76e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.49e-06	2.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	1.49e-06	2.76e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.49e-06	2.76e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.49e-06	2.76e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.49e-06	2.75e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-06	2.74e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.48e-06	2.73e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.48e-06	2.73e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.48e-06	2.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.48e-06	2.73e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.47e-06	2.73e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.47e-06	2.72e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.47e-06	2.72e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.47e-06	2.72e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.47e-06	2.72e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.47e-06	2.72e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.46e-06	2.71e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.46e-06	2.71e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.46e-06	2.71e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.46e-06	2.71e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.46e-06	2.69e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.45e-06	2.69e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.45e-06	2.68e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.45e-06	2.68e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.45e-06	2.68e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.43e-06	2.65e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.43e-06	2.64e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.42e-06	2.63e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.42e-06	2.63e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.42e-06	2.62e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.41e-06	2.62e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.41e-06	2.61e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.41e-06	2.61e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	1.4e-06	2.59e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.4e-06	2.58e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.39e-06	2.57e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.39e-06	2.56e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.38e-06	2.55e-05	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.38e-06	2.55e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.38e-06	2.55e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.38e-06	2.54e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.37e-06	2.53e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.37e-06	2.53e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.36e-06	2.52e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.36e-06	2.52e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.36e-06	2.51e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.36e-06	2.51e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.36e-06	2.51e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.35e-06	2.5e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.34e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.33e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.33e-06	2.47e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.33e-06	2.46e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.33e-06	2.46e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.33e-06	2.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.32e-06	2.43e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.32e-06	2.43e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.31e-06	2.43e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.31e-06	2.43e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.31e-06	2.43e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.31e-06	2.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.31e-06	2.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.31e-06	2.41e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.31e-06	2.41e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.3e-06	2.4e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.3e-06	2.4e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.3e-06	2.4e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.29e-06	2.38e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.29e-06	2.38e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.28e-06	2.37e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.28e-06	2.37e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.28e-06	2.36e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.28e-06	2.36e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.28e-06	2.36e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.27e-06	2.35e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.27e-06	2.35e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.27e-06	2.34e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.26e-06	2.33e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.26e-06	2.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.26e-06	2.32e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.25e-06	2.31e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.25e-06	2.31e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.25e-06	2.31e-05	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.24e-06	2.3e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.24e-06	2.29e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.24e-06	2.29e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.24e-06	2.28e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.23e-06	2.28e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.23e-06	2.27e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.22e-06	2.26e-05	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-06	2.26e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.22e-06	2.26e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.22e-06	2.25e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.21e-06	2.25e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.21e-06	2.24e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.21e-06	2.24e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.21e-06	2.23e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.21e-06	2.23e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.21e-06	2.23e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.21e-06	2.23e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.2e-06	2.23e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.2e-06	2.22e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.2e-06	2.22e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.19e-06	2.2e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.19e-06	2.2e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.19e-06	2.2e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.19e-06	2.2e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.19e-06	2.19e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.19e-06	2.19e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.18e-06	2.18e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.17e-06	2.16e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.16e-06	2.15e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.16e-06	2.15e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.16e-06	2.14e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.16e-06	2.14e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.15e-06	2.13e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.15e-06	2.13e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.15e-06	2.13e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.15e-06	2.13e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.15e-06	2.12e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.14e-06	2.11e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.14e-06	2.11e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.14e-06	2.11e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.14e-06	2.11e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.14e-06	2.1e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.14e-06	2.1e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.13e-06	2.1e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.13e-06	2.09e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.13e-06	2.09e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.13e-06	2.09e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.13e-06	2.09e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.13e-06	2.08e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.12e-06	2.06e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.1e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.1e-06	2.04e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.1e-06	2.03e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.09e-06	2.01e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.09e-06	2.01e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.08e-06	1.99e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.07e-06	1.98e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.07e-06	1.98e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.06e-06	1.97e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.06e-06	1.96e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.06e-06	1.96e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.06e-06	1.95e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.05e-06	1.93e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.04e-06	1.93e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.04e-06	1.93e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.04e-06	1.93e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.04e-06	1.92e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.04e-06	1.92e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.04e-06	1.92e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.02e-06	1.89e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.02e-06	1.88e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.01e-06	1.86e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1e-06	1.85e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1e-06	1.85e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	9.98e-07	1.84e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	9.9e-07	1.83e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	9.87e-07	1.82e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.81e-07	1.81e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	9.81e-07	1.81e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	9.79e-07	1.81e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	9.77e-07	1.81e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.77e-07	1.81e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	9.74e-07	1.8e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	9.7e-07	1.79e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	9.64e-07	1.78e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.61e-07	1.78e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.6e-07	1.77e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	9.59e-07	1.77e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	9.52e-07	1.76e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.51e-07	1.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.44e-07	1.74e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.41e-07	1.74e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.41e-07	1.74e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	9.36e-07	1.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.35e-07	1.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.29e-07	1.72e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.22e-07	1.7e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.11e-07	1.68e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	9.11e-07	1.68e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	9.1e-07	1.68e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	8.97e-07	1.66e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.97e-07	1.66e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	8.94e-07	1.65e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.84e-07	1.63e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.82e-07	1.63e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.79e-07	1.62e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.77e-07	1.62e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	8.75e-07	1.62e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.74e-07	1.62e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	8.72e-07	1.61e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.65e-07	1.6e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	8.58e-07	1.59e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	8.58e-07	1.59e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.57e-07	1.58e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.54e-07	1.58e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	8.49e-07	1.57e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	8.45e-07	1.56e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	8.38e-07	1.55e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	8.33e-07	1.54e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	8.29e-07	1.53e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.15e-07	1.51e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	8.05e-07	1.49e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	8.01e-07	1.48e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.93e-07	1.47e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	7.89e-07	1.46e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	7.85e-07	1.45e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.84e-07	1.45e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.68e-07	1.42e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	7.64e-07	1.41e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	7.6e-07	1.4e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	7.52e-07	1.39e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	7.49e-07	1.38e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	7.45e-07	1.38e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.4e-07	1.37e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.39e-07	1.37e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.28e-07	1.35e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.27e-07	1.34e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	7.27e-07	1.34e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.23e-07	1.34e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	7.14e-07	1.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.14e-07	1.32e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	6.76e-07	1.25e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.67e-07	1.23e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	6.65e-07	1.23e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.65e-07	1.23e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	6.52e-07	1.21e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.4e-07	1.18e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.23e-07	1.15e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.13e-07	1.13e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	6.05e-07	1.12e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.91e-07	1.09e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5.87e-07	1.08e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.61e-07	1.04e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.61e-07	1.04e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	5.55e-07	1.03e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.49e-07	1.01e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.45e-07	1.01e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	5.24e-07	9.69e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.13e-07	9.49e-06	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.06e-07	9.36e-06	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	4.19e-07	7.74e-06	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.95e-07	7.29e-06	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.34e-07	6.18e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.58e-07	4.77e-06	CbGpPWpGaD
